loading

Finanzdaten der Longboard Pharmaceuticals Inc-Aktie (LBPH)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
16.29%
18.11
15.57 13.58 15.64 11.96
Operating Income/Loss
16.29%
-18.11
-15.57 -13.58 -15.64 -11.96
Income/Loss From Continuing Operations Before Tax
0.31%
-14.99
-15.03 -12.93 -15.00 -11.46
Income/Loss From Continuing Operations After Tax
0.31%
-14.99
-15.03 -12.93 -15.00 -11.46
Net Income/Loss
0.31%
-14.99
-15.03 -12.93 -15.00 -11.46
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
8,185%
35.32
0.4263 23.49 22.97 20.41
Diluted Average Shares
8,185%
35.32
0.4263 23.49 22.97 20.41
Basic Earnings Per Share
32.26%
-0.42
-0.62 -0.55 -0.65 -0.56
Diluted Earnings Per Share
32.26%
-0.42
-0.62 -0.55 -0.65 -0.56
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Kapitalisierung:     |  Volumen (24h):